Key result
Carotid tandem lesion stenting is linked to ~21% stent thrombosis, frequently at the bifurcation.
Why the study?
Stent thrombosis reaches 20% after emergent carotid stenting for acute ischemic stroke, but the specific role of the stent itself in driving thrombosis remains unknown.
Does stent design (presence or absence of mesh at the bifurcation) affect thrombus formation in a carotid artery model?
Observational
Does stent design (presence or absence of mesh at the bifurcation) affect thrombus formation in a carotid artery model?
Carotid stents placed across the bifurcation create a high-shear prothrombotic environment, and modifying stent design to omit mesh at the bifurcation may reduce acute stent thrombosis.
May guide targeted prevention of stent thrombosis after emergent carotid stenting; leaves open need for prospective validation before practice change.
Background Stent thrombosis is a serious complication of angioplasty with stenting, as evidenced by the associated morbidity and mortality events. Its incidence is particularly elevated after emergent carotid stenting in patients with acute ischemic stroke, reaching 20%. A better understanding of the mechanisms driving stent thrombosis will open up new avenues to limit this alarming complication. Its 2 main determinants are the ruptured atherosclerotic plaque and the stent itself, whose particular role in the process remains unknown. Methods Using a new macrofluidic model mimicking the geometry of the human carotid artery, the intrinsic thrombogenicity of carotid stents was evaluated. Results Real‐time video microscopy combined with scanning electron microscopy revealed that the Casper and the Wallstent, 2 widely used commercial stents, are thrombogenic and promote the formation of a massive thrombus in the carotid bifurcation (Casper: median, 9 [interquartile range, 6.4–24.4]×10 5 μm 2 ; Wallstent: median, 9.5 [interquartile range, 1.5–20.8]×10 5 μm 2 ). This result was consistent with a retrospective clinical study in stented patients with tandem lesions, in which 21.1% presented stent thrombosis, and 38.7% of these cases occurred at the bifurcation. Moreover, a stent lying in the carotid bifurcation of the macrofluidic model generated a prothrombotic high‐shear environment, triggering thrombosis, which was prevented in the presence of aspirin or abciximab. Finally, stents with a new design could avoid the formation of large thrombi in the carotid bifurcation (full stent: median, 8.9 [interquartile range, 7.8–17.2]×10 5 μm 2 ; stent with an opening at the bifurcation: median, 2.1 [interquartile range, 1.1–3]×10 5 μm 2 ), opening up the perspective of new ways to prevent carotid stent thrombosis. Conclusions Stents placed inside the carotid bifurcation are responsible for a massive thrombus formation that could lead to stent thrombosis. The absence of mesh prevents its formation.
No takes yet. Share an insight, caveat, or question.
Kern et al. (2026) conducted an observational in Tandem lesions in acute ischemic stroke. Carotid stenting was evaluated on Stent thrombosis. In a retrospective clinical study of stented patients with tandem lesions, 21.1% presented stent thrombosis, with 38.7% of these cases occurring at the carotid bifurcation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: